Rani Therapeutics: Oral Biologics Vision Still Has Early-Stage Risks
Source: SeekingAlpha
2025-11-05 15:22:53 ET
...
Read the full article on Seeking Alpha
For further details see:
Rani Therapeutics: Oral Biologics Vision Still Has Early-Stage Risks
Chugai Pharmaceutical
NASDAQ: CHGCF
CHGCF Trading
1.92% G/L:
$61.2525 Last:
411 Volume:
$61.2525 Open:
